Stock screenerAll disclosures →
EDGAR →
CTMX
Conviction 47HealthcareScan · Mon, Aug 10, 2026CTMX$3.42-1.16%
ResistanceSupportVol 14Vol MA14 2.85M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price3.42
Change-1.16%
Gap-0.58%
Rel volume3.50×
Avg volume3.48M
Avg $ vol11.92M
SMA 203.38
SMA 503.36
SMA 2004.18
Price vs 50+1.86%
Price vs 200-18.24%
MA stackmixed
50/200 cross—
Supertrenddown · 3.64
RSI (14)51
MACD hist0.02
MACD crossbull · 1d
Stoch %K / %D76 / 70
ADX (14)16
+DI / −DI22 / 17
RSI divergence—
MACD divergence—
ATR %+5.10%
ADR %4.76%
52w high6.75
52w low1.76
From 52w high-49.33%
Above 52w low+94.32%
New 52w highNo
SqueezeOff
Bollinger width20.24%
%B0.56
Donchian pos51.25%
Donchian high3.81
Donchian low3.01
AVWAP (52w high)4.57
vs AVWAP high-25.20%
AVWAP (52w low)4.24
vs AVWAP low-19.40%
OBV trendDown
Chaikin MF (20)-0.14
Today vs 20d3.50×
Avg vol (14d)2.85M
Avg vol (20d)3.48M
Avg $ vol (20d)11.92M
Market cap745.22M
RS 3m (vs SPY)-19.20%
RS 6m (vs SPY)-48.08%
RS line new highNo
Trend template4/8
Technical rank22.8
1 week+7.89%
1 month-9.04%
3 months-14.07%
6 months-39.68%
1 year+62.86%
YTD-19.53%
P/E-42.91
P/B2.47
P/S9.78
P/FCF-9.83
EPS-1.16
Div yield—
ROE-5.75%
ROA-4.56%
Debt/Eq0.01
Current9.36
EV/EBITDA-35.69
Gross margin—
Net margin-22.79%
Rev growth-44.82%
EPS growth-154.50%
Price target11.67
Target upside241.23%
Analyst ratingBuy
Institutional101.90%
Ent. value730.98M
Revenue1.42M
Net income-20.67M
Gross profit—
Free cash flow-75.81M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out217.7M
Employees69
ListedThu, Oct 8, 2015
Free float199.76M
Float %91.8%
Short interest40.32M
Days to cover10.4d
Short volume62.6%
Squeeze score95 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.09 vs −$0.11
Last surprise+18.2% beat
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank22.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.96
Support2.94
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CTMX
No recent disclosed trades by Congress in CTMX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CTMX · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Carvajal Alejandra Chief Legal Officer · Common Stock · 2026-08-03 | Grant | 100K | — | 2026-08-03 | 2026-08-05 |
Carvajal Alejandra Chief Legal Officer · Stock Option (Right to Buy) · 2026-08-03 | Grant | 450K | — | 2026-08-03 | 2026-08-05 |
Su Zhen Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 59K | — | 2026-06-17 | 2026-06-22 |
Jones Elaine V Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 59K | — | 2026-06-17 | 2026-06-22 |
Gilbert Halley E Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 59K | — | 2026-06-17 | 2026-06-22 |
Ashworth Alan Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 59K | — | 2026-06-17 | 2026-06-22 |
Meyers James R Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 59K | — | 2026-06-17 | 2026-06-22 |
Mohindru Mani Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 59K | — | 2026-06-17 | 2026-06-22 |
Young Matthew P. Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 59K | — | 2026-06-17 | 2026-06-22 |
SEC filings
EDGAR filings in CTMX · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.